The term "leucoaraiosis" (from
greek araiosis rare, and
leuko white) was first used by Hachinski to describe WM
hypodensities found on Computed Tomography in the
brain of vascular patients. Its use was widely extended with
MR to describe a large group of T2W hyperintensities of
unexplained etiologies, but mainly found in brain of patients
with vascular risks factors. The terms like UBO
(Unidentified bright objects), incidental cortical lesions,
have been also used
The term "leucoaraiosis" (from
greek araiosis rare, and
leuko white) was first used by Hachinski to describe WM
hypodensities found on Computed Tomography in the
brain of vascular patients. Its use was widely extended with
MR to describe a large group of T2W hyperintensities of
unexplained etiologies, but mainly found in brain of patients
with vascular risks factors. The terms like UBO
(Unidentified bright objects), incidental cortical lesions,
have been also used
The term "leucoaraiosis" (from
greek araiosis rare, and
leuko white) was first used by Hachinski to describe WM
hypodensities found on Computed Tomography in the
brain of vascular patients. Its use was widely extended with
MR to describe a large group of T2W hyperintensities of
unexplained etiologies, but mainly found in brain of patients
with vascular risks factors. The terms like UBO
(Unidentified bright objects), incidental cortical lesions,
have been also used
The term "leucoaraiosis" (from
greek araiosis rare, and
leuko white) was first used by Hachinski to describe WM
hypodensities found on Computed Tomography in the
brain of vascular patients. Its use was widely extended with
MR to describe a large group of T2W hyperintensities of
unexplained etiologies, but mainly found in brain of patients
with vascular risks factors. The terms like UBO
(Unidentified bright objects), incidental cortical lesions,
have been also used
The term "leucoaraiosis" (from
greek araiosis rare, and
leuko white) was first used by Hachinski to describe WM
hypodensities found on Computed Tomography in the
brain of vascular patients. Its use was widely extended with
MR to describe a large group of T2W hyperintensities of
unexplained etiologies, but mainly found in brain of patients
with vascular risks factors. The terms like UBO
(Unidentified bright objects), incidental cortical lesions,
have been also used